Skip to main content

Table 2 Baseline characteristics of study subjects by one-year outcome status among HIV-1-infected pulmonary tuberculosis patients, Uganda, 1993–1995

From: Gender and HIV-associated pulmonary tuberculosis: presentation and outcome at one year after beginning antituberculosis treatment in Uganda

Characteristic

Favorable Outcome (Alive and cured at 1-year) (N = 169)

Unfavorable Outcome (Dead or not cured at 1-year) (N = 45)

p value

Categorical variables:

n (%)

n (%)

 

Demographic

   

Educated

157 (92.9)

45(100)

0.02

Married

135(79.9)

37(82.2)

0.72

Past Medical History

   

Fever

102(60.4)

34(75.6)

0.06

Cough

165(97.6)

45(100)

0.30

Sweats

109(64.5)

30(66.7)

0.79

Hemoptysis

20(11.8)

4(8.9)

0.58

Diarrhea

17(10.1)

9(20.0)

0.07

Herpes zoster

6(3.6)

3(6.7)

0.36

Genital ulcers

32(18.9)

11(24.4)

0.41

Thrush

5(3.0)

12(26.7)

<0.005

BCG scar

93(55.0)

25(55.6)

0.95

Chest radiography

   

Cavitary disease

104(61.5)

22(48.9)

0.12

Fibrosis

37(21.9)

3(6.7)

0.02

Upper lung disease

140(82.8)

33(73.3)

0.15

Continuous variables:

Means (SD)

Means (SD)

 

Age (years)

29.1(6.2)

29.5(6.4)

0.69

Weight (Kg)

51.9(7.5)

49.0(8.1)

<0.005

Body mass index (Kg/m2)

19.5(2.7)

18.4(2.6)

<0.005

Tuberculin skin test result (mm)

15.7(6.2)

10.8(7.2)

<0.005

β2 microglobulin (g)

6.2(2.5)

6.9(4.3)

<0.005

Absolute CD4 cell count (cells/μl)

428(313)

207(273)

<0.005

Hemoglobin (g/dl)

10.6(2.2)

9.6(2.5)

0.01

WBC (cells × 1000/ μl)

7.6(2.6)

7.1(3.4)

0.41

Duration of symptoms (months)

   

Fever

2.5(2.5)

3.1(3.7)

0.39

Sweats

2.8(2.7)

2.0(1.9)

0.09

Diarrhea

1.3(1.7)

1.4(1.6)

0.89

Signs

   

Temperature (° Celsius)

37.0(1.9)

37.0(1.0)

0.95

Karnofsky score (%)

83.1(6.1)

79.1(7.3)

<0.005

Extent of disease on x-ray

2.5(0.7)

2.3 (0.7)

0.15

  1. 1 = Minimal 2 = Moderate 3 = Advanced